Cargando…
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans
We used data obtained by Caris Life Sciences, to evaluate the benefits of tailoring treatments for a breast carcinoma cohort by using tumor molecular profiles to inform decisions. Data for 92 breast cancer patients from the commercial Caris Molecular Intelligence database was retrospectively divided...
Autores principales: | Carter, Philip, Alifrangis, Costi, Cereser, Biancastella, Chandrasinghe, Pramodh, Del Bel Belluz, Lisa, Moderau, Nina, Poyia, Fotini, Schwartzberg, Lee S., Tabassum, Neha, Wen, Jinrui, Krell, Jonathan, Stebbing, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915140/ https://www.ncbi.nlm.nih.gov/pubmed/29707132 http://dx.doi.org/10.18632/oncotarget.24564 |
Ejemplares similares
-
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments
por: Alifrangis, Costi, et al.
Publicado: (2018) -
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
por: Carter, Philip, et al.
Publicado: (2018) -
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
por: Carter, Philip, et al.
Publicado: (2018) -
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018) -
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018)